Skip to content

LYNAPHARMA

Active Private limited companyfounded 2016active for 9 yearsAlsembergse Steenweg 135, 1060 Sint-Gillis (bij-Brussel)KBO/BCE: BE 0666.517.583
LYNAPHARMA
Follow ReportCompare

Board

1 director, last change in 2024
GHALEB Anissa
Director (not named in the articles)
since 21-11-2016 term without a fixed end
earlier manager, until 26-02-2024
listed in the 2025 annual accounts, filed on 27-10-2026

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
GHALEB Anissa
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
  • GHALEB Anissa
    • Director (not named in the articles), from 21-11-2016 to date
    • Manager, until 26-02-2024

Control

See the annual accounts at the National Bank and the publications in the Belgian Official Gazette.

Capital

Contribution
€66,000
Source
deed of 26-02-2024

Articles of association

deed of 26-02-2024 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Moitie cedant moitie acquereurs proportionnellement aux actions acquises…”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Friday of June at 18:00

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure